menu Search
Atorsam-F

Atorsam-F Use In Pregnancy & Lactation

Manufacturer:

Samson Laboratories

Distributor:

Khriz Pharma
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Full Prescribing Info
Use In Pregnancy & Lactation
HMG CoA Reductase Inhibitors decrease cholesterol synthesis and possibly the synthesis of other biologically active substances derived from cholesterol and may cause fetal harm when administered to the pregnant woman. Furthermore, the safety of Fenofibrate in pregnant women has not been established. Because of the potential for adverse reactions, the fixed dose combination of Atorvastatin and Fenofibrate is contraindicated during pregnancy in women and in nursing mothers.